Retraction notice to “CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer” [Acta Histochemica 115 (2013) 349–356](S006512811200116X)(10.1016/j.acthis.2012.09.007);CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer

Acta Histochemica

Volumn 115, Issue 4, 2013, Pages 349-356

  Wang, Dongqing ^a   Zhu, Haitao ^a   Zhu, Ying ^a   Liu, Yanfang ^a   Shen, Huiling ^a   Yin, Ruigen ^a   Zhang, Zhijian ^a   Su, Zhaoliang ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Drug resistance; MDR1; Panc 1; Pancreatic cancer stem cell

Indexed keywords

CD133 ANTIGEN; HERMES ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; METASTASIS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PANCREAS CANCER; PANCREATIC CANCER STEM CELL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD44; ANTIMETABOLITES, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYCYTIDINE; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MICE; MICE, SCID; NEOPLASM METASTASIS; NERVE TISSUE PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; P-GLYCOPROTEIN; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876329717     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2018.03.005     Document Type: Erratum

References (35)

1. Albini A., Cesana E., Noonan D.M. Cancer stem cells and the tumor microenvironment: soloists or choral singers. Curr Pharm Biotechnol 2011, 12:171-181.
2. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
3. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
4. Braat H., Bruno M., Kuipers E.J., Peppelenbosch M.P. Pancreatic cancer: promise for personalised medicine?. Cancer Lett 2012, 318:1-8.
5. Burris H., Storniolo A.M. Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur J Cancer 1997, 33(Suppl 1):S18-S22.
6. Burris H.A., Moore M.J., Andersen J., Green M.R., Rothenberg M.L., Modiano M.R., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997, 15:2403-2413.
7. Carlesso N., Cardoso A.A. Stem cell regulatory niches and their role in normal and malignant hematopoiesis. Curr Opin Hematol 2010, 17:281-286.
8. Di Fiore R., Santulli A., Ferrante R.D., Giuliano M., De Blasio A., Messina C., et al. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 2009, 219:301-313.
9. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008, 15:504-514.
10. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004, 64:7011-7021.
11. Ghods A.J., Irvin D., Liu G., Yuan X., Abdulkadir I.R., Tunici P., et al. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 2007, 25:1645-1653.
12. Hermann P.C., Huber S.L., Heeschen C. Metastatic cancer stem cells: a new target for anti-cancer therapy?. Cell Cycle 2008, 7:188-193.
13. Hermann P.C., Mueller M.T., Heeschen C. Pancreatic cancer stem cells - insights and perspectives. Expert Opin Biol Ther 2009, 9:1271-1278.
14. Hong S.P., Wen J., Bang S., Park S., Song S.Y. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. Int J Cancer 2009, 125:2323-2331.
15. Huang Y. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy. Cancer Metastasis Rev 2007, 26:183-201.
16. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
17. Kawasaki B.T., Hurt E.M., Mistree T., Farrar W.L. Targeting cancer stem cells with phytochemicals. Mol Interventions 2008, 8:174-184.
18. Konopleva M., Tabe Y., Zeng Z., Andreeff M. Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches. Drug Resist Updat 2009, 12:103-113.
19. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., et al. Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-1037.
20. Lowery M.A., O'Reilly E.M. Pancreatic adenocarcinoma: new approaches to a challenging malignancy. Oncology (Williston Park) 2010 2010, 24:1339-1342.
21. Marsden C.G., Wright M.J., Pochampally R., Rowan B.G. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action. Methods Mol Biol 2009, 590:363-375.
22. Na Y.R., Seok S.H., Kim D.J., Han J.H., Kim T.H., Jung H., et al. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4. Tumour Biol 2009, 30:300-309.
23. Nieto J., Grossbard M.L., Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty?. Oncologist 2008, 13:562-576.
24. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005, 65:5506-5511.
25. Reed J.C. Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol 2006, 3:388-398.
26. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
27. Rosenberg L. Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine. Int J Pancreatol 1997, 22:81-93.
28. Rothenberg M.L., Abbruzzese J.L., Moore M., Portenoy R.K., Robertson J.M., Wanebo H.J. A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer 1996, 78:627-632.
29. Salmaggi A., Boiardi A., Gelati M., Russo A., Calatozzolo C., Ciusani E., et al. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006, 54:850-860.
30. Sneddon J.B., Werb Z. Location, location, location: the cancer stem cell niche. Cell Stem Cell 2007, 607-611.
31. Stavrovskaya A.A., Stromskaya T.P. Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry (Mosc) 2008, 73:592-604.
32. Takaishi S., Okumura T., Tu S., Wang S.S., Shibata W., Vigneshwaran R., et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27:1006-1020.
33. Yin T., Wei H., Gou S., Shi P., Yang Z., Zhao G., et al. Cancer stem-like cells enriched in panc-1 spheres possess increased migration ability and resistance to gemcitabine. Int J Mol Sci 2011, 12:1595-1604.
34. Yuan X., Curtin J., Xiong Y., Liu G., Waschsmann-Hogiu S., Farkas D.L., et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23:9392-9400.
35. Zhong Y., Guan K., Guo S., Zhou C., Wang D., Ma W., et al. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett 2010, 299:150-160.